Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 250 movers: Bodycote trades higher on Deutsche Bank target price bump, AML heads south on profit warning
(Sharecast News) - London's FTSE 250 was down 0.11% at 22,173.30 in afternoon trade on Monday. Bodycote shares rallied on Monday after Deutsche Bank reiterated its 'buy' rating on the stock and lifted its price target from 700p to 860p, as the engineering group's Aerospace & Defence division continued to reshape its growth and margin profile.
Deutsche Bank said the unit had reached "critical mass" and was driving structural improvements not yet priced into the stock. "We believe that the Bodycote of the future will be faster growing, making structurally better margins, and demanding a revisit from the market on its ascribed quality," said DB. The German bank added that it remains confident in Bodycote's ability to meet its FY28 financial targets.
Shares in Oxford Biomedia traded higher after RBC Capital lifted its price target on the stock to 970p from 930p on Monday, reiterating its 'outperform' rating as it flagged upside potential from the gene therapy group's pipeline.
The Canadian broker said late-stage and commercial programmes could deliver up to £150m in peak revenues, while early-stage assets may be worth twice as much, with both estimates doubling on a non-risk-adjusted basis. RBC added that the valuation uplift reflects growing confidence in Oxford Biomedica's long-term growth trajectory.
Aston Martin Lagonda headed south after it warned on profits and launched an immediate review of costs on Monday, after US tariffs crashed third-quarter demand. The British luxury car marque said it delivered 1,430 wholesale units during the three-month period, below guidance for around 1,641.
It blamed the shortfall on weaker-than-expected demand in North America, due to Donald Trump's swingeing tariff regime, and in the Asia-Pacific region, including China.
Shares in low-cost carrier Wizz Air flew lower after Ryanair boss Michael O'Leary launched a scathing attack on rival carriers, warning of fresh bankruptcies across Europe and claiming Wizz "has no future" as the Irish low-cost giant ramps up competition in key regional markets.
O'Leary said: "The problem in Europe is that there are many airlines pretending to be low cost, but they have a high-cost structure. PLAY never made a profit. And there will be other small operators struggling in the market. There will be more bankruptcies before Christmas. I also think Wizz Air is in trouble. I don't think it will collapse in the coming weeks, but I think it's inevitable that at some point it will either fail or be acquired by someone."
Reporting by Iain Gilbert at Sharecast.com
FTSE 250 - Risers
Bodycote (BOY) 674.00p 3.53% Oxford Biomedica (OXB) 634.00p 3.09% W.A.G Payment Solutions (EWG) 94.00p 2.84% Vietnam Enterprise Investments (DI) (VEIL) 759.00p 2.71% Energean (ENOG) 829.50p 2.53% Bakkavor Group (BAKK) 213.00p 2.40% IntegraFin Holding (IHP) 359.50p 1.99% Baillie Gifford Japan Trust (BGFD) 936.00p 1.96% Rathbones Group (RAT) 1,874.00p 1.96% BlackRock World Mining Trust (BRWM) 691.00p 1.77%
FTSE 250 - Fallers
Aston Martin Lagonda Global Holdings (AML) 75.45p -7.20% QinetiQ Group (QQ.) 508.50p -5.04% Raspberry PI Holdings (RPI) 413.90p -2.98% Travis Perkins (TPK) 631.00p -2.47% Foresight Group Holdings Limited NPV (FSG) 480.00p -2.24% Marshalls (MSLH) 177.20p -2.10% 4Imprint Group (FOUR) 3,270.00p -2.10% Wizz Air Holdings (WIZZ) 1,182.00p -2.07% Pennon Group (PNN) 468.40p -2.01% CMC Markets (CMCX) 224.50p -1.97%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.